Heterozygous Disruption of SERCA2a is Not Associated with Impairment of Cardiac Performance in Humans: Implications for SERCA2a As a Therapeutic Target in Heart Failure

Overview

Journal Heart

Date 2005 Apr 23

PMID 15845614

Citations 13

Authors

B M Mayosi

A Kardos

C H Davies

F Gumedze

A Hovnanian

S Burge

H Watkins

Affiliations

Soon will be listed here.

Abstract

Objective: To verify whether a deficiency in the cardiac sarcoplasmic reticulum pump SERCA2a causes cardiac dysfunction in humans.

Design: Cardiac performance was measured in a serendipitous human model of primary SERCA2a deficiency, Darier's disease, an autosomal dominant skin disorder caused by mutations inactivating one copy of the ATP2A2 gene, which encodes SERCA2a.

Methods: Systolic and diastolic function and contractility were assessed by echocardiography at rest and during exercise in patients with Darier's disease with known mutations. Fourteen patients with Darier's disease were compared with 14 normal controls and six patients with dilated cardiomyopathy with stable heart failure.

Results: Resting systolic and diastolic function was normal in patients with Darier's disease and in controls. The increase in systolic function during exercise was not different between patients with Darier's disease and normal controls; neither was there a difference in contractility. As expected, patients with dilated cardiomyopathy had impaired diastolic and systolic function with depressed contractility at rest and during exercise.

Conclusion: Contrary to expectations, heterozygous disruption of SERCA2a is not associated with the impairment of cardiac performance in humans. Attempts to increase SERCA2a levels in heart failure, although showing promise in rodent studies, may not be addressing a critical causal pathway in humans.

Citing Articles

Cardiovascular consequences of sickle cell disease.

Palomarez A, Jha M, Medina Romero X, Horton R Biophys Rev (Melville). 2024; 3(3):031302.

PMID: 38505276 PMC: 10903381. DOI: 10.1063/5.0094650.

Cardiomyocyte-specific PCSK9 deficiency compromises mitochondrial bioenergetics and heart function.

Laudette M, Lindbom M, Arif M, Cinato M, Ruiz M, Doran S Cardiovasc Res. 2023; 119(7):1537-1552.

PMID: 36880401 PMC: 10318396. DOI: 10.1093/cvr/cvad041.

Preclinical models of radiation-induced cardiac toxicity: Potential mechanisms and biomarkers.

Dreyfuss A, Velalopoulou A, Avgousti H, Bell B, Verginadis I Front Oncol. 2022; 12:920867.

PMID: 36313656 PMC: 9596809. DOI: 10.3389/fonc.2022.920867.

Advances in Preclinical Research Models of Radiation-Induced Cardiac Toxicity.

Schlaak R, SenthilKumar G, Boerma M, Bergom C Cancers (Basel). 2020; 12(2).

PMID: 32053873 PMC: 7072196. DOI: 10.3390/cancers12020415.

Primary Active Ca Transport Systems in Health and Disease.

Chen J, Sitsel A, Benoy V, Sepulveda M, Vangheluwe P Cold Spring Harb Perspect Biol. 2019; 12(2).

PMID: 31501194 PMC: 6996454. DOI: 10.1101/cshperspect.a035113.

References

Barry W . Molecular inotropy: a future approach to the treatment of heart failure?. Circulation. 1999; 100(23):2303-4. DOI: 10.1161/01.cir.100.23.2303. View

Sakuntabhai A, Burge S, Monk S, Hovnanian A . Spectrum of novel ATP2A2 mutations in patients with Darier's disease. Hum Mol Genet. 1999; 8(9):1611-9. DOI: 10.1093/hmg/8.9.1611. View

Miyamoto M, Del Monte F, Schmidt U, DiSalvo T, Kang Z, Matsui T . Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A. 2000; 97(2):793-8. PMC: 15410. DOI: 10.1073/pnas.97.2.793. View

Suman O, Hasten D, Turner M, Rinder M, Spina R, Ehsani A . Enhanced inotropic response to dobutamine in strength-trained subjects with left ventricular hypertrophy. J Appl Physiol (1985). 2000; 88(2):534-9. DOI: 10.1152/jappl.2000.88.2.534. View

Ji Y, Lalli M, Babu G, Xu Y, Kirkpatrick D, Liu L . Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function. J Biol Chem. 2000; 275(48):38073-80. DOI: 10.1074/jbc.M004804200. View

Tavadia S, Tait R, McDonagh T, Munro C . Platelet and cardiac function in Darier's disease. Clin Exp Dermatol. 2001; 26(8):696-9. DOI: 10.1046/j.1365-2230.2001.00921.x. View

Mayosi B, Keavney B, Kardos A, Davies C, Ratcliffe P, Farrall M . Electrocardiographic measures of left ventricular hypertrophy show greater heritability than echocardiographic left ventricular mass. Eur Heart J. 2002; 23(24):1963-71. DOI: 10.1053/euhj.2002.3288. View

Frank K, Bolck B, Erdmann E, Schwinger R . Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc Res. 2002; 57(1):20-7. DOI: 10.1016/s0008-6363(02)00694-6. View

Haghighi K, Kolokathis F, Pater L, Lynch R, Asahi M, Gramolini A . Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest. 2003; 111(6):869-76. PMC: 153772. DOI: 10.1172/JCI17892. View

10.

Ahn W, Lee M, Kim K, Muallem S . Multiple effects of SERCA2b mutations associated with Darier's disease. J Biol Chem. 2003; 278(23):20795-801. DOI: 10.1074/jbc.M301638200. View

11.

Schmidt A, Haghighi K, Frank B, Pater L, Dorn G, Walsh R . Polymorphic SERCA2a variants do not account for inter-individual differences in phospholamban-SERCA2a interactions in human heart failure. J Mol Cell Cardiol. 2003; 35(7):867-70. DOI: 10.1016/s0022-2828(03)00111-1. View

12.

Dode L, Andersen J, Leslie N, Dhitavat J, Vilsen B, Hovnanian A . Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses. J Biol Chem. 2003; 278(48):47877-89. DOI: 10.1074/jbc.M306784200. View

13.

Borow K, GREEN L, Grossman W, Braunwald E . Left ventricular end-systolic stress-shortening and stress-length relations in human. Normal values and sensitivity to inotropic state. Am J Cardiol. 1982; 50(6):1301-8. DOI: 10.1016/0002-9149(82)90467-2. View

14.

Missiaen L, Wuytack F, Raeymaekers L, De Smedt H, Droogmans G, Declerck I . Ca2+ extrusion across plasma membrane and Ca2+ uptake by intracellular stores. Pharmacol Ther. 1991; 50(2):191-232. DOI: 10.1016/0163-7258(91)90014-d. View

15.

Arai M, Matsui H, Periasamy M . Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res. 1994; 74(4):555-64. DOI: 10.1161/01.res.74.4.555. View

16.

Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J . Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res. 1994; 75(3):434-42. DOI: 10.1161/01.res.75.3.434. View

17.

Pieske B, Kretschmann B, Meyer M, Holubarsch C, Weirich J, Posival H . Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation. 1995; 92(5):1169-78. DOI: 10.1161/01.cir.92.5.1169. View

18.

Davies C, Davia K, Bennett J, Pepper J, Poole-Wilson P, Harding S . Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation. 1995; 92(9):2540-9. DOI: 10.1161/01.cir.92.9.2540. View

19.

Davies C, Harding S, Poole-Wilson P . Cellular mechanisms of contractile dysfunction in human heart failure. Eur Heart J. 1996; 17(2):189-98. DOI: 10.1093/oxfordjournals.eurheartj.a014834. View

20.

Davia K, Davies C, Harding S . Effects of inhibition of sarcoplasmic reticulum calcium uptake on contraction in myocytes isolated from failing human ventricle. Cardiovasc Res. 1997; 33(1):88-97. DOI: 10.1016/s0008-6363(96)00187-3. View